199 related articles for article (PubMed ID: 35494063)
21. Clinicopathological and Genomic Profiles of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma Identify Overlapping Signatures with a High Mutational Burden.
Ak M; Kahraman A; Arnold FM; Turko P; Levesque MP; Zoche M; Ramelyte E; Dummer R
Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34202213
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for local atypical fibroxanthoma recurrence and progression to pleomorphic dermal sarcoma: A meta-analysis of individualized participant data.
Ørholt M; Aaberg FL; Abebe K; Walsh S; Roenigk RK; Venzo A; Schmidt G; Klyver H; Jensen DH; Herly M; Vester-Glowinski PV
J Surg Oncol; 2022 Sep; 126(3):555-562. PubMed ID: 35441377
[TBL] [Abstract][Full Text] [Related]
23. Atypical fibroxanthoma/pleomorphic dermal sarcoma of the scalp with aberrant expression of HMB-45: a pitfall in dermatopathology.
Piras V; Ferreli C; Atzori L; Pinna G; Pilloni L
Pathologica; 2020 Jun; 112(2):105-109. PubMed ID: 32760054
[TBL] [Abstract][Full Text] [Related]
24. Pleomorphic dermal sarcoma: Clinicopathological features and outcomes from a 5-year tertiary referral centre experience.
Logan IT; Vroobel KM; le Grange F; Perrett CM
Cancer Rep (Hoboken); 2022 Nov; 5(11):e1583. PubMed ID: 34766474
[TBL] [Abstract][Full Text] [Related]
25. Expression of proton-sensing G-protein-coupled receptors in selected skin tumors.
Nassios A; Wallner S; Haferkamp S; Klingelhöffer C; Brochhausen C; Schreml S
Exp Dermatol; 2019 Jan; 28(1):66-71. PubMed ID: 30339292
[TBL] [Abstract][Full Text] [Related]
26. The many faces of Atypical fibroxanthoma.
Agaimy A
Semin Diagn Pathol; 2023 Jul; 40(4):306-312. PubMed ID: 37438163
[TBL] [Abstract][Full Text] [Related]
27. Fine needle aspiration cytopathology of pleomorphic dermal sarcoma.
Challa BS; Plaza JA; Wakely PE
Cytopathology; 2023 Sep; 34(5):472-478. PubMed ID: 37204069
[TBL] [Abstract][Full Text] [Related]
28. Copy number variations in atypical fibroxanthomas and pleomorphic dermal sarcomas.
Helbig D; Quaas A; Mauch C; Merkelbach-Bruse S; Büttner R; Emberger M; Wobser M; Rüsseler V; Pütz K; Binot E; Rehker J; Budczies J; Ihle MA
Oncotarget; 2017 Dec; 8(65):109457-109467. PubMed ID: 29312620
[TBL] [Abstract][Full Text] [Related]
29. Atypical Fibroxanthoma Treated with a Topical Combination of Imiquimod, Tazarotene, and 5-Fluorouracil.
Nahm WJ; Badiavas EV; Kirsner RS; Boyd CJ; Arthur AA; Bae S; Shen J
Dermatol Ther (Heidelb); 2024 Apr; 14(4):1049-1056. PubMed ID: 38467988
[TBL] [Abstract][Full Text] [Related]
30. Atypical fibroxanthoma and pleomorphic dermal sarcoma: A reappraisal.
Cesinaro AM; Gallo G; Tramontozzi S; Migaldi M
J Cutan Pathol; 2021 Feb; 48(2):207-210. PubMed ID: 32583897
[TBL] [Abstract][Full Text] [Related]
31. Pleomorphic dermal sarcoma: it might be rare but it exists.
Seretis K; Klaroudas A; Galani V; Papathanakos G; Varouktsi A; Mitselou A; Batistatou A; Lampri E
J Surg Case Rep; 2023 Aug; 2023(8):rjad374. PubMed ID: 37545789
[TBL] [Abstract][Full Text] [Related]
32. Clear cell variant of atypical fibroxanthoma and pleomorphic dermal sarcoma: Molecular characterization and review of the literature.
Coelho-Lima J; Bruty J; Watkins J; Liu H; Price R; Stefanos N
J Cutan Pathol; 2022 Dec; 49(12):1031-1034. PubMed ID: 35922373
[TBL] [Abstract][Full Text] [Related]
33. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
[TBL] [Abstract][Full Text] [Related]
34. Expression of 3q oncogene
Müller CSL; Kreie L; Bochen F; Pfuhl T; Smola S; Gräber S; Vogt T; Schick B; Linxweiler M
Oncol Lett; 2019 Feb; 17(2):1768-1776. PubMed ID: 30675236
[TBL] [Abstract][Full Text] [Related]
35. Pleomorphic Dermal Sarcoma of the Scalp.
Klebanov N; Hoang MP; Reddy BY
Cureus; 2018 Jul; 10(7):e2979. PubMed ID: 30237940
[TBL] [Abstract][Full Text] [Related]
36. Sarcoma-like tumor of head and neck skin.
Nonaka D; Bishop PW
Am J Surg Pathol; 2014 Jul; 38(7):956-65. PubMed ID: 24705313
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical expression of melanocytic and myofibroblastic markers and their molecular correlation in atypical fibroxanthomas and pleomorphic dermal sarcomas.
Helbig D; Mauch C; Buettner R; Quaas A
J Cutan Pathol; 2018 Dec; 45(12):880-885. PubMed ID: 30155964
[TBL] [Abstract][Full Text] [Related]
38. Atypical fibroxanthoma: An analysis of 105 tumors.
Bitel A; Schönlebe J; Krönert C; Wollina U
Dermatol Ther; 2020 Nov; 33(6):e13962. PubMed ID: 32618393
[TBL] [Abstract][Full Text] [Related]
39. Pleomorphic dermal sarcoma: a clinical and histological review of 49 cases.
Bowe CM; Godhania B; Whittaker M; Walsh S
Br J Oral Maxillofac Surg; 2021 May; 59(4):460-465. PubMed ID: 33441282
[TBL] [Abstract][Full Text] [Related]
40. Pleomorphic dermal sarcoma of the scalp: Review of management and distinguishing features from atypical fibroxanthoma.
Cohen AJ; Talasila S; Lazarevic B; Gleason L; Patel V; Nikbakht N
JAAD Case Rep; 2022 Nov; 29():123-126. PubMed ID: 36262359
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]